Tetraphase Slumps: TTPH Falls 10.3% in Session - Tale of the Tape

Tetraphase Pharmaceuticals, Inc. TTPH saw a big move last session, as the company's shares fell by over 10% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for TTPH as the stock is now down over 22% since April 2.

The biopharmaceutical company has seen a mixed track record when it comes to current year estimate revisions over the past few weeks. However, the current year consensus for loss has widened over the last 30 days. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

Tetraphase currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.0%.

Some better-ranked stocks in the same sector include Shire SHPG, Astellas Pharma, Inc. (ALPMY) and IntelliPharmaCeutics International Inc. IPCI. All these stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ASTELLAS PHARMA (ALPMY): Get Free Report

INTELLIPHARMACT IPCI: Free Stock Analysis Report

SHIRE PLC-ADR SHPG: Free Stock Analysis Report

TETRAPHASE PHAR TTPH: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs